Genolution Stock Earnings Per Share
225220 Stock | KRW 2,175 70.00 3.12% |
Genolution fundamentals help investors to digest information that contributes to Genolution's financial success or failures. It also enables traders to predict the movement of Genolution Stock. The fundamental analysis module provides a way to measure Genolution's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Genolution stock.
Genolution |
Genolution Company Earnings Per Share Analysis
Genolution's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
Competition |
According to the company disclosure, Genolution has an Earnings Per Share of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Biotechnology & Medical Research (which currently averages 0.0) industry. This indicator is about the same for all Republic of Korea stocks average (which is currently at 0.0).
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
All Next | Launch Module |
Genolution Fundamentals
Return On Equity | 27.23 | |||
Profit Margin | 0.43 % | |||
Operating Margin | 0.65 % | |||
Current Valuation | 34.7 B | |||
Shares Owned By Insiders | 25.54 % | |||
Shares Owned By Institutions | 0.10 % | |||
Revenue | 72.83 B | |||
Gross Profit | 63.24 B | |||
EBITDA | 67.13 B | |||
Net Income | 34.39 B | |||
Cash And Equivalents | 33.91 B | |||
Debt To Equity | 0.1 % | |||
Current Ratio | 4.38 X | |||
Cash Flow From Operations | 25.73 B | |||
Beta | -0.23 | |||
Market Capitalization | 93.7 B | |||
Total Asset | 94.94 B | |||
Annual Yield | 0.02 % | |||
Net Asset | 94.94 B |
About Genolution Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Genolution's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Genolution using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Genolution based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Genolution
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Genolution position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genolution will appreciate offsetting losses from the drop in the long position's value.Moving together with Genolution Stock
0.72 | 278650 | KNOTUS CoLtd | PairCorr |
0.67 | 288330 | Bridge Biotherapeutics | PairCorr |
0.89 | 293780 | AptaBio Therapeutics | PairCorr |
0.65 | 217330 | Cytogen | PairCorr |
Moving against Genolution Stock
0.91 | 035420 | Naver | PairCorr |
0.84 | 041510 | SM Entertainment | PairCorr |
0.8 | 032640 | LG Uplus | PairCorr |
0.77 | 078160 | MEDIPOST | PairCorr |
0.71 | 011390 | Busan Industrial | PairCorr |
The ability to find closely correlated positions to Genolution could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Genolution when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Genolution - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Genolution to buy it.
The correlation of Genolution is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Genolution moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Genolution moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Genolution can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Genolution Stock
Genolution financial ratios help investors to determine whether Genolution Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genolution with respect to the benefits of owning Genolution security.